Study on Risk Factors and TCM Syndrome Distribution of T2DM Accompanied by MAFLD_Vol. 1 No. 2 (JMHS 2023)_Journal of Medicine and Health Science (ISSN: 2959-0639)

Home > Journal of Medicine and Health Science (ISSN: 2959-0639) > Vol. 1 No. 2 (JMHS 2023) >

Study on Risk Factors and TCM Syndrome Distribution of T2DM Accompanied by MAFLD

Download PDF

DOI: https://doi.org/10.62517/jmhs.202305207

Author(s)

Jia Yan , Fenping Li*

Affiliation(s)

Shaanxi University of Chinese Medicine, Xianyang , Shaanxi 712046, China

Abstract

This paper mainly studies the risk factors of type 2 diabetes combined with metabolic fatty liver disease and the distribution of TCM syndrome types by incorporating case comparison diagnosis and observation, in order to identify the main inducements of type 2 diabetes combined with metabolic fatty liver disease, and to provide guidance for clinical diagnosis and treatment.

Keywords

T2DM Accompanied by MAFLD; TCM Syndrome; Risk Factors

References

[1] Zhang Lili, Weng Xiaogang, Yao Shufan (2023). Correlation between Blood Glucose Fluctuation and Type 2 Diabetes Combined with Metabolic Fatty Liver Disease. Journal of Xinxiang Medical University, 40 (05): 427-431. [2] Kong Dexian, Xing Yuling, Sun Wenwen, et al (2023). Study on the Correlation between Estimated Glucose Treatment Rate and Type 2 Diabetes with Metabolic Fatty Liver Disease. China General Practice, 26 (26): 3252-3258. [3] Qian Fangfang, Li Haoxiang, Shen Yirong, et al (2023). Correlation between Monocyte/High-density Lipoprotein Cholesterol Ratio and Insulin Resistance in Male Type 2 Diabetes Patients with Metabolic Fatty Liver Disease. China Tropical Medicine, 23 (04): 333-337. DOI: 10.13604/j.cnki.46-1064/r.2023.04.02. [4] Yin Meiqi, Jin Lijuan, Liu Yuanjun, et al (2023). Observation on the Efficacy of Wumen Tiaozhi Granule in Treating Obese Type 2 Diabetes with Metabolic Fatty Liver Disease. Western Journal of Traditional Chinese Medicine, 36 (04): 97-100. [5] Zheng Panpan, Zhao Weili, Hu Qingshan, etc. Study on the Influencing Factors of Type 2 Diabetes Combined with Metabolic Fatty Liver Disease. Chinese Journal of Diabetes, 2023,31 (02): 99-103. [6] Xu Ting, Li Yuanyuan, Chen Yue, et al (2022). Correlation between Serum S100A8/A9 and sRAGE levels and Type 2 Diabetes with Metabolic Fatty Liver Disease. Journal of Tropical Medicine, 22 (11): 1502-1506+1550. [7] Xing Lixuan, Chen Man, Lin Lili, etc (2021). Study on the Risk Factors and Distribution of TCM Syndrome of Type 2 Diabetes Combined with Metabolic Fatty Liver Disease. Shanxi Traditional Chinese Medicine, 37 (08): 48-51.